Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

AxioMed Spine

Request full access

AxioMed Spine develops products that restore the spinal function of patients with degenerative spine diseases

Fort Lauderdale, United StatesFounded 2001Biotech & Life Sciences

About AxioMed Spine

Axiomed is a pioneering company in the medical device industry, specializing in next-generation total disc replacement solutions. The company focuses on developing innovative, one-piece disc replacement devices designed to provide both flexibility and support, thereby facilitating pain relief and the restoration of normal spinal function for patients suffering from degenerative disc disease. Axiomed serves a diverse range of clients, including healthcare providers, hospitals, and clinics that treat spinal conditions. Operating in the global medical device market, Axiomed's business model revolves around the research, development, and commercialization of advanced spinal care technologies. The company generates revenue through the sale of its proprietary disc replacement devices and related services. By leveraging cutting-edge technology and a patient-centric approach, Axiomed aims to redefine patient outcomes and improve the quality of life for individuals with spinal disorders.

Source: Dealroom company data

At a glance

Status
Operational
Employees
15
Open positions
None listed
Dealroom signal
78.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Spinout, Orthopedic, Biotech and Pharma, DT and LS, science-based
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Aug 2022 $12M $48M Undisclosed ↗
DEBTDebt Jan 2017 $1M — Undisclosed —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

AxioMed Spine website traffic

Latest recorded traffic for AxioMed Spine is 500 monthly website visits, down 15.3% over the last three months. AxioMed Spine's team grew 15.4% over the past year.

Latest monthly visits500 3-month web change-15.3% 1-year team growth+15.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
CollplantRegenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing Ness Ziona, Israel Operational 48 $18M $4.8M
BioSenicFor autoimmune, inflammatory and bone diseases Mont-Saint-Guibert, Belgium Operational
Myonexus TherapeuticsA Clinical Stage Limb-Girdle Muscular Dystrophy Gene Therapy Company New Albany, United States Acquired
Eloxx PharmaceuticalsEloxx Pharmaceuticals focuses on the discovery, development, and commercialization of compounds for the treatment of rare genetic diseases, including cystic fibrosis, Duchenne muscular dystrophy, Usher syndrome, ataxia-telangiectasia, beta thalassemi Watertown, United States Acquired
Audentes TherapeuticsAudentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases. San Francisco, United States Acquired
BioMimetic TherapeuticsProvider of orthopedic consultation and health care to patients Round Rock, United States Acquired
Pluristem TherapeuticsPluristem Therapeutics Inc. (NasdaqCM: $PSTI, TASE: PSTI/PLTR) is a clinical-stage biotherapy company developing placenta-based cell therapy products Israel Operational
Spear BioOffers opportunities for better detections with less invasive biospecimen collection Woburn, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

AxioMed Spine in the Fort Lauderdale ecosystem

Live from Dealroom

The AxioMed Spine office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Reservoir Venture Partners
  • Early Stage Partners
  • CID Equity Partners
  • Thomas McNerney & Partners
  • Primus Venture Partners
  • MB Venture Partners

Series B and later2 investors entered at this stage

  • Primus Capital Partners
  • Investor Growth Capital

Other known investors1 additional known investor

  • Cleveland Clinic Lerner College of Medicine
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States50%
🇬🇧 United Kingdom16.7%
🇲🇦 Morocco16.7%
🇰🇷 South Korea16.7%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about AxioMed Spine on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AxioMed Spine’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.